The Linear No-Threshold Model of Low-Dose Radiogenic Cancer: A Failed Fiction.

Dose Response

Nuclear Physics Enterprises, Marlton, NJ, USA.

Published: February 2019

The linear no-threshold (LNT) model for low-dose, radiogenic cancer has been a fixture of radiation protection and regulatory requirements for decades, but its validity has long been contested. This article finds, yet again, more questionable data and analyses purporting to support the model, this within the "gold-standard" data set for estimating radiation effects in humans. Herein is addressed a number of significant uncertainties in the Radiation Effects Research Foundation's Life Span Study (LSS) cohort of atomic bomb survivors, especially in its latest update of 2017, showing that the study's support of the LNT model is not evidence based. We find that its latest 2 analyses of solid cancer incidence ignore biology and do not support the LNT model. Additionally, we identify data inconsistencies and missing causalities in the LSS data and analyses that place reliance on uncertain, imputed data and apparently flawed modeling, further invalidating the LNT model. These observations lead to a most credible conclusion, one supporting a threshold model for the dose-response relationship between low-dose radiation exposure and radiogenic cancer in humans. Based upon these findings and those cited from others, it becomes apparent that the LNT model cannot be scientifically valid.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376521PMC
http://dx.doi.org/10.1177/1559325818824200DOI Listing

Publication Analysis

Top Keywords

lnt model
20
radiogenic cancer
12
linear no-threshold
8
model
8
model low-dose
8
low-dose radiogenic
8
data analyses
8
radiation effects
8
support lnt
8
lnt
5

Similar Publications

Lentinan inhibits melanoma development by regulating the AKT/Nur77/Bcl-2 signaling axis.

J Cancer

January 2025

Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou, Fujian 363000, People's Republic of China.

Melanoma is a highly malignant and difficult-to-treat skin cancer. Many researchers are exploring natural products for its treatment. Lentinan (LNT), extracted from , exerts strong anti-tumor effects.

View Article and Find Full Text PDF

Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model.

Biomaterials

May 2025

State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong Key Laboratory of Non-Human Primate Research, GHM Institute of CNS Regeneration, Department of Chemistry, Jinan University, Guangzhou, 510632, China; Department of Psychiatry, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China; Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, 226019, China; Department of Neurology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, 570100, China. Electronic address:

Selenium (Se) is incorporated into selenoproteins in the form of selenocysteine, which has biological functions associated with neural development. Unfortunately, the specific roles and mechanisms of selenoproteins at different stages of neuronal development are still unclear. Therefore, in this study, we successfully established a neuronal model derived from induced pluripotent stem cells (iPSC-iNeuron) and used Se nanoparticles (SeNPs@LNT) with high bioavailability to intervene at different stages of neural development in iPSC-iNeuron model.

View Article and Find Full Text PDF
Article Synopsis
  • The current radiation protection standards for cancer risk, primarily based on the Life Span Study (LSS), lack sufficient supporting evidence for low-dose ionizing radiation (LDIR) effects.
  • There is a growing need for substantial evidence and potential thresholds for cancer risk, especially with increased medical radiation use, prompting a review of epidemiological studies.
  • Recent advances in understanding the biology of LDIR-induced cancer suggest that factors like DNA damage, chromosome changes, and stem cell behavior may challenge existing risk models, indicating new areas for future research.
View Article and Find Full Text PDF

Background: Breast screening recommendation based on individual risk assessment is emerging as an alternative approach to improve compliance and efficiency to detect breast cancer (BC) early. In Vietnam, prior knowledge to stratify risk based on genetic factors is currently lacking.

Methods: This study recruited 892 BC patients and 735 healthy Vietnamese women from 2016 to 2021.

View Article and Find Full Text PDF

Random Threshold Model: A Low-Dose Radiation-Induced Risk Assessment Approach Considering Individual Susceptibility to Cancer.

Dose Response

November 2024

Department of Biomedical Science and Technology, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.

The linear no-threshold (LNT) model, which has been used for radiation protection purposes, was developed based on the assumption that exposure to even a small amount of radiation may cause cancer. However, although it is known in carcinogenesis that there is variation in radiation sensitivity among individuals, the LNT model does not adequately consider radiosensitive subgroups. In this paper, we represent susceptibility to contract cancer by radiation exposure by means of the threshold of a dose-response function, introduce an assumption that the thresholds are random to represent the variation of the radiosensitivity among individuals in a susceptible subgroup.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!